ARC Capital in the Australia-China biotech invest

ARC Capital in the Australia-China biotech invest

Last Monday, ARC Capital was involved in the Australia-China biotech invest 2017, the place to find Biotech innovators from around the world and partnership opportunities. with leading-edge technologies.

The program took place on Monday 27 March at the Marriott in Shanghai. The program featured company presentations, keynote speakers, lively panel discussions and was the perfect location for us to meet potential clients.

We discuss with the following companies in order to cooperate together:

  • Petri Exchange
  • Biotron
  • Novogen
  • FivepHusion
  • ResApp

The upcoming partnerships is an indication of ARC Capital’s capabilities to assist both public and private listed companies.

Continue reading

ARC Group's 2026 Capital Markets & M&A Forum Concludes in Shanghai, Exploring New Pathways for Overseas Listings and Global Expansion

ARC Group's 2026 Capital Markets & M&A Forum Concludes in Shanghai, Exploring New Pathways for Overseas Listings and Global Expansion

Shanghai, China, September 4, 2026: ARC Group, a global investment bank and management consultancy, successfully concluded its Capital Markets and M&A Forum 2026: China Edition on September 3 at the Waldorf Astoria Shanghai on the Bund. The forum brought together business leaders, investors, and professional advisors from investment banking, law, audit, investor relations, and other […]
Exascale Labs Holdings Inc. Announces Closing of Business Combination with D. Boral ARC Acquisition I Corp. and Commencement of Trading on Nasdaq Under Ticker Symbol “XLAB”
Countdown Begins for ARC Group's 2026 Capital Markets and M&A Forum, Opening September 3 in Shanghai to Spotlight Overseas Listings, Cross-Border M&A, and the Global Expansion of Chinese Enterprises
Xinhua News Features ARC Group: Advising China’s Mid-Market on Global Expansion

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission